Related Experiment Video
Updated: Dec 8, 2025

Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
Acute and chronic kidney disease after pediatric liver transplantation: An underestimated problem
Antonio Lacquaniti1, Susanna Campo1, Teresa Casuscelli Di Tocco1
1Department of Internal Medicine, Nephrology and Dialysis Unit, Papardo Hospital of Messina, Messina, Italy.
Insights
Kidney injuries are common after pediatric liver transplantation (LTx), with acute issues early on and chronic damage developing later. Early diagnosis and tailored treatments are crucial for managing kidney function and improving outcomes in these children.
Area of Science:
- Pediatric Nephrology
- Transplantation Medicine
- Immunology
Background:
- Kidney injuries are a significant concern post-liver transplantation (LTx), particularly in children, where data is limited.
- Accurate renal function assessment is challenging in liver disease patients due to confounding factors.
- Standard creatinine-based equations often underestimate renal disease severity in end-stage liver disease.
Purpose of the Study:
- To review acute and chronic kidney damage following pediatric liver transplantation.
- To discuss the influence of pre-existing renal disease on post-LTx kidney outcomes.
- To analyze immunosuppressive strategies and their impact on renal function in pediatric LTx recipients.
Main Methods:
- Literature review of acute and chronic kidney injury after pediatric liver transplantation.
- Analysis of renal function assessment methods, including novel biomarkers.
- Review of current and alternative immunosuppression protocols.
Main Results:
- Renal dysfunction is a critical issue after pediatric liver transplantation.
- Early post-LTx kidney issues are often acute, while later damage (5-7 years) tends to be chronic and irreversible.
- Immunosuppression regimens, including calcineurin inhibitors, corticosteroids, mycophenolate mofetil, and sirolimus, significantly impact kidney function.
Conclusions:
- Early diagnosis and personalized management are essential for kidney disease in pediatric LTx patients to reduce mortality.
- Understanding the impact of immunosuppression on renal function is key for optimizing long-term outcomes.
- Further research into new renal biomarkers is needed for improved kidney function assessment.
Abstract:
Acute and chronic kidney injuries represent critical issues after liver transplantation (LTx), but whereas renal dysfunction in adult transplant patients is well documented, little is known about its prevalence in childhood. It is a challenge to accurately evaluate renal function in patients with liver disease, due to several confounding factors. Creatinine-based equations estimating glomerular filtration rate, validated in nephropathic patients without hepatic issues, are frequently inaccurate in end-stage liver disease, underestimating the real impact of renal disease. Moreover, whereas renal issues observed within 1 year from LTx were often related to acute injuries, kidney damage observed after 5-7 years from LTx, is due to chronic, irreversible mechanisms. Most immunosuppression protocols are based on calcineurin inhibitors (CNIs) and corticosteroids, but mycophenolate mofetil or sirolimus could play significant roles, also in children. Early diagnosis and personalized treatment represent the bases of kidney disease management, in order to minimize its close relation with increased mortality. This review analyzed acute and chronic kidney damage after pediatric LTx, also discussing the impact of pre-existent renal disease. The main immunosuppressant strategies have been reviewed, highlighting their impact on kidney function. Different methods assessing renal function were reported, with the potential application of new renal biomarkers.
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
Acute Kidney Injury I: Introduction
Kidney Transplant III: Nursing Management
Chronic Kidney Disease I: Introduction

